You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 100 No. 2, August 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  THERAPY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (41)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Vitiligo With Topical Methoxsalen and Blacklite

James E. Fulton, Jr., MD; James Leyden, MD; Christopher Papa, MD

Arch Dermatol. 1969;100(2):224-229.


Abstract

Fourteen of 15 vitiligo patients responded to the topical use of methoxsalen and subsequent exposure to long-wave ultraviolet light. Three of the subjects showed complete repigmentation. Adverse reactions were prevented by using a controlled energy source with a light emission pattern corresponding to the biologic action spectrum of the photosensitizer. As a delayed 48 to 72 hour erythema was produced, only weekly treatments were necessary.

Repigmentation began after two to ten treatments and migrated out from the hair follicles or advanced in from the borders of the vitiliginous areas. This repigmentation was associated with the migration of Dopa-positive melanocytes into the treated areas.



Author Affiliations

Philadelphia

From the Division of Dermatology, University of Pennsylvania School of Medicine, Philadelphia. Dr. Fulton is now at the Department of Dermatology, University of Miami Medical School, Miami, Fla.


Footnotes

Accepted for publication Dec 17, 1968.

Reprint requests to the Department of Dermatology, University of Miami Medical School, Miami, Fla 33136 (Dr. Fulton).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Localized Vitiligo by Autologous Minigrafting
Falabella
Arch Dermatol 1988;124:1649-1655.
ABSTRACT  

Topically Administered Fluorouracil in Vitiligo
Tsuji and Hamada
Arch Dermatol 1983;119:722-727.
ABSTRACT  

Autoantibodies and Their Clinical Significance in a Black Vitiligo Population
Grimes et al.
Arch Dermatol 1983;119:300-303.
ABSTRACT  

Photochemotherapy of Vitiligo: Use of Orally Administered Psoralens and a High-Intensity Long-Wave Ultraviolet Light System
Parrish et al.
Arch Dermatol 1976;112:1531-1534.
ABSTRACT  

Factors Influencing Methoxsalen Phototoxicity in Vitiliginous Skin
Arora and Willis
Arch Dermatol 1976;112:327-332.
ABSTRACT  

Psoralen Plus Black Light Inhibits Epidermal DNA Synthesis
Walter et al.
Arch Dermatol 1973;107:861-865.
ABSTRACT  

Prevention of Unintentional Overexposure in Topical Psoralen Treatment of Vitiligo
Parrish et al.
Arch Dermatol 1971;104:281-283.
ABSTRACT  

Society Transactions
Arch Dermatol 1971;104:212-217.
ABSTRACT  

Vitiligo Treated by Psoralens: A Long-Term Follow-Up Study of the Permanency of Repigmentation
Kenney
Arch Dermatol 1971;103:475-480.
ABSTRACT  

FALSE NEGATIVE IMMEDIATE PHOTOPATCH TEST TO TRIBROMSALAN
Shelmire
Arch Dermatol 1971;103:223-224.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.